The acquisition of San Diego-based ValueGene expands IDT's presence in Southern California.
The company said FEI's technology will complement its mass spectrometry business, particularly in its work on structural proteins and biopharmaceuticals.
The acquisition will give India's MedGenome access to a CLIA-certified and CAP-accredited laboratory in the Bay Area so that it can expand its operations in the US.
The genomics company is set to acquire LifebankUSA, which was founded by HLI's own co-founder, from Celgene's Cellular Therapeutics subsidiary.
The UK diagnostics company is selling the subsidiary back to its two cofounders less than two years after buying it.
The Beckman Coulter unit provides genomic sequencing solutions to healthcare businesses, governments, and academia around the world.
The firm also secured a loan commitment from Oberland Capital SA Davos for up to $50 million, which it will use to help fund the acquisition.
The healthcare diagnostics company has agreed to purchase Pathology's operating assets for an undisclosed amount.
The deal creates a science sector giant able to "cover every step of the biotech production chain."
Tute will offer interpretation and annotation software from Knome's KnoSys appliance as part of its existing cloud offering but is open to providing a local option for interested clients.
A man has confessed to the rape and murder of developmental biologist Suzanne Eaton, according to the New York Times.
The Irish Times reports that US lawmakers and law enforcement agencies are concerned about ties between the US and Chinese genomics firms.
Parents of children with spinal muscular atrophy tell the Washington Post they are pushing to get insurance coverage of Novartis's Zolgensma.
In PNAS this week: gene mutations in individuals with syndromic craniosynostosis, putative colorectal cancer drivers, and more.